Palm Stimulator Use During Peripheral Venous Catheterization

Starting soon · Not applicable

Conditions studied: Procedural Pain, Cancer, Fear Needles, Anxiety, Catheterization, Peripheral Venous

In brief

Purpose: The purpose of this study is to evaluate the effectiveness of a "Palm Stimulator" (a handheld device with blunt protrusions) in reducing pain, fear, and anxiety during peripheral venous catheterization (IV insertion) in adult cancer patients receiving chemotherapy. Methods: This is a randomized controlled clinical trial. Participants will be randomly assigned to either the Experimental Group or the Control Group. Experimental Group: During the IV insertion process, patients will hold and squeeze the Palm Stimulator in the palm of their non-procedural hand. The device is designed to provide intense tactile (touch) stimulation based on the "Gate Control Theory." Control Group: Patients will receive the standard routine care for IV insertion without any additional intervention. Data Collection: Pain intensity will be measured using the Visual Analog Scale (VAS), while fear and anxiety levels will be assessed through VAS scales before and after the procedure. Patient satisfaction with the device will also be recorded. Expected Outcome: The investigators hypothesize that the use of the Palm Stimulator will significantly decrease procedural pain and fear while increasing patient satisfaction compared to standard care. This study aims to provide a low-cost, non-pharmacological, and easy-to-use tool for oncology nurses to improve patient comfort during invasive procedures.

Key facts

Study ID

NCT07387497

Run by

Zeliha CENGİZ

People needed

90

Starts

2026-02-20

Expected to finish

2026-07-30

Last updated by the study team

2026-02-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18-65 years.
• Receiving chemotherapy treatment via peripheral venous catheter (PVC).
• Cognitively capable of communicating and responding to pain, fear, and satisfaction scales.
• Volunteering to participate and providing written informed consent.

You may not qualify if…

• Diagnosis of chemotherapy-induced peripheral neuropathy or diabetic neuropathy.
• Presence of active infection, open wound, scar tissue, or edema in the palm.
• Use of analgesic medication within 4-6 hours before the procedure.
• History of hemiplegia or movement restriction in the extremity to be used for the procedure.

Where it is running

• Turgut Ozal Medical Center — Malatya, Malatya, Turkey (Türkiye)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.